The oncology department hub — ten multi-society clinical guideline series covering central venous access in cancer patients, extravasation, cancer-associated thrombosis, febrile neutropenia, CINV, mucositis, hazardous drug handling, cancer pain, immunotherapy adverse events, and survivorship.
Oncology supportive care is the clinical discipline of keeping cancer treatment deliverable and survivable — securing reliable vascular access for months of therapy, preventing and managing treatment toxicities, protecting the clinicians who handle hazardous drugs, and following patients into survivorship. This section of The Clinical Database is the oncology hub: ten evidence-based clinical guideline series covering the supportive care backbone of cancer treatment.
Each series is a multi-society synthesis: recommendations from several authoritative sources — the ASCO central venous catheter care guideline, ASCO/IDSA febrile neutropenia guidance, the INS Infusion Therapy Standards of Practice, and others — are integrated into a single, copyright-free reference with full DOI-linked citations, then split into sequential part pages so each part is individually citable. Every page carries a published date and a lastmod date; prefer lastmod when citing.
For how the series are constructed and maintained, see the Oncology Clinical Guidelines hub.
| Series | Covers | Parts |
|---|---|---|
| Central Venous Access Devices in Oncology | Device selection and assessment, insertion and site care, maintenance, complications, special populations, quality | 1 · 2 · 3 · 4 · 5 |
| Chemotherapy Extravasation | Vesicant/irritant classification, prevention, recognition, antidote protocols, follow-up, documentation | 1 · 2 · 3 |
| Cancer-Associated Thrombosis | Risk assessment (Khorana), prophylaxis, DOAC/LMWH treatment, special situations, CVAD-related thrombosis | 1 · 2 · 3 · 4 · 5 |
The central venous access series is written for the oncology context. For device-level guidance independent of oncology — port access, tunneled catheters, CVC care and removal — see the Central Venous Catheters guide tree in the Vascular Access department.
| Series | Covers | Parts |
|---|---|---|
| Febrile Neutropenia | Risk stratification (MASCC/CISNE), empiric antibiotics, outpatient management, prophylaxis and G-CSF, antifungals, line infections | 1 · 2 · 3 · 4 |
| CINV Prevention & Management | Emetogenic classification, antiemetic pharmacology, regimens by risk tier, assessment and implementation | 1 · 2 · 3 · 4 |
| Oral & GI Mucositis | Pathobiology and grading, oral mucositis prevention and management, GI and radiation mucositis, HSCT | 1 · 2 · 3 |
| Series | Covers | Parts |
|---|---|---|
| Safe Handling of Hazardous Drugs | Drug identification and risk assessment, engineering controls, PPE, spills and waste, surveillance and training | 1 · 2 · 3 · 4 |
| Cancer Pain Management | Assessment, analgesic ladder, opioid selection and rotation, adjuvants and interventional approaches, CIPN, special populations | 1 · 2 · 3 · 4 · 5 |
| Series | Covers | Parts |
|---|---|---|
| Immune Checkpoint Inhibitor Adverse Events | Grade-based irAE management by organ system, corticosteroid protocols, immunosuppressive escalation, rechallenge | 1 · 2 · 3 · 4 · 5 |
| Oncology Survivorship Care | Care plans and surveillance by cancer type, cardio-oncology, late effects, psychosocial health, care models and financial toxicity | 1 · 2 · 3 · 4 · 5 |
Each series has the same anatomy. The series hub (first column above) carries the clinical framing, a contents table describing what each part covers, and the complete source list with full citations in its footnotes. The part pages carry the substance in reading order, each individually addressable — the antidote protocols for extravasation, the equianalgesic dosing content, the grade-based irAE tables — so a specific part can be bookmarked, cited, or shared on its own.
For protocol and order-set development, start at the series hub: the source list identifies which society documents your institutional standard must reconcile, and the parts show where those sources agree and diverge. For point-of-care reference, deep-link the part page closest to the decision; the part titles above are written to be findable from a search.
The section’s boundaries are deliberate. Device-level vascular access procedure — port access technique, dressing changes, tunneled catheter care — lives in the Vascular Access department, and the oncology series link into it rather than duplicating it. Patient-facing material lives in patient education. Institution-ready policy documents, including antineoplastic therapy administration and hazardous drug management, live in the policy library.
Oncology patients move through every other department on this site; the adjacent hubs carry the connected content: